Literature DB >> 11106640

COUP-TF1 antagonizes Nkx2.5-mediated activation of the calreticulin gene during cardiac development.

L Guo1, J Lynch, K Nakamura, L Fliegel, H Kasahara, S Izumo, I Komuro, L B Agellon, M Michalak.   

Abstract

Calreticulin, a Ca(2+) binding chaperone of the endoplasmic reticulum, is also highly expressed in the embryonic heart, and knockout of the calreticulin gene is lethal during embryogenesis because of impaired cardiac development. The protein is down-regulated after birth, and elevated expression of calreticulin in newborn hearts is associated with severe cardiac pathology and death. Here we show that the transcription factor Nkx2.5 activates expression of the calreticulin gene in the heart. Binding of chicken ovalbumin upstream promoter-transcription factor 1 to the Nkx2.5 binding site suppresses transcription from the calreticulin promoter. Nkx2.5 and chicken ovalbumin upstream promoter-transcription factor 1 play antagonistic roles in regulating the expression of calreticulin during cardiac development. These studies indicate that cardiac-specific transcription factor Nkx2.5 plays a central role in activating calreticulin expression and that there is a cooperation between chicken ovalbumin upstream promoter-transcription factor 1 and Nkx2.5 at the calreticulin promoter.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106640     DOI: 10.1074/jbc.C000822200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Intracellular organelles in the saga of Ca2+ homeostasis: different molecules for different purposes?

Authors:  Enrico Zampese; Paola Pizzo
Journal:  Cell Mol Life Sci       Date:  2011-10-04       Impact factor: 9.261

2.  Complete heart block and sudden death in mice overexpressing calreticulin.

Authors:  K Nakamura; M Robertson; G Liu; P Dickie; K Nakamura; J Q Guo; H J Duff; M Opas; K Kavanagh; M Michalak
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

3.  Calreticulin in the heart.

Authors:  Marek Michalak; Lei Guo; Murray Robertson; Mira Lozak; Michal Opas
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

4.  Estradiol differentially regulates calreticulin: a potential link with abnormal T cell function in systemic lupus erythematosus?

Authors:  J M Ward; V Rider; N I Abdou; B Kimler
Journal:  Lupus       Date:  2013-03-27       Impact factor: 2.911

5.  Calreticulin expression: Interaction with the immune infiltrate and impact on survival in patients with ovarian and non-small cell lung cancer.

Authors:  Gautier Stoll; Kristina Iribarren; Judith Michels; Alexandra Leary; Laurence Zitvogel; Isabelle Cremer; Guido Kroemer
Journal:  Oncoimmunology       Date:  2016-06-09       Impact factor: 8.110

Review 6.  Calreticulin and cancer.

Authors:  Mohammadreza Zamanian; Abhi Veerakumarasivam; Syahril Abdullah; Rozita Rosli
Journal:  Pathol Oncol Res       Date:  2013-02-08       Impact factor: 3.201

7.  Genome-wide analysis of androgen receptor targets reveals COUP-TF1 as a novel player in human prostate cancer.

Authors:  Ruth Perets; Tommy Kaplan; Ilan Stein; Guy Hidas; Shay Tayeb; Eti Avraham; Yinon Ben-Neriah; Itamar Simon; Eli Pikarsky
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

8.  Calreticulin induces dilated cardiomyopathy.

Authors:  Dukgyu Lee; Tatsujiro Oka; Beth Hunter; Alison Robinson; Sylvia Papp; Kimitoshi Nakamura; Wattamon Srisakuldee; Barbara E Nickel; Peter E Light; Jason R B Dyck; Gary D Lopaschuk; Elissavet Kardami; Michal Opas; Marek Michalak
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

9.  Genome-wide association analysis and fine mapping of NT-proBNP level provide novel insight into the role of the MTHFR-CLCN6-NPPA-NPPB gene cluster.

Authors:  Fabiola Del Greco M; Cristian Pattaro; Andreas Luchner; Irene Pichler; Thomas Winkler; Andrew A Hicks; Christian Fuchsberger; Andre Franke; Scott A Melville; Annette Peters; H Erich Wichmann; Stefan Schreiber; Iris M Heid; Michael Krawczak; Cosetta Minelli; Christian J Wiedermann; Peter P Pramstaller
Journal:  Hum Mol Genet       Date:  2011-01-27       Impact factor: 6.150

10.  The small muscle-specific protein Csl modifies cell shape and promotes myocyte fusion in an insulin-like growth factor 1-dependent manner.

Authors:  S Palmer; N Groves; A Schindeler; T Yeoh; C Biben; C C Wang; D B Sparrow; L Barnett; N A Jenkins; N G Copeland; F Koentgen; T Mohun; R P Harvey
Journal:  J Cell Biol       Date:  2001-05-28       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.